NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

David Feigal, MD, MPH

Practice Area Focus

  • Development Strategy
  • Regulatory Strategy
  • Drugs & Biologics
  • Devices
  • Combination Products
  • Antiviral Drug

Biography

David Feigal, MD, is a Partner in NDA Partners. He spent 12 years with the US Food & Drug Administration (FDA) where he was Director, Center for Devices & Radiological Health (CDRH), Director, Division of Anti-infective & Antiviral Drug Products, Center for Drug Evaluation & Research (CDER), and Deputy Director, Center for Biologics Evaluation & Research (CBER). He is former Vice President of Global Regulatory Strategy, Amgen, and former Senior Vice President, Head of Global Regulatory and Global Safety Surveillance at Elan Corporation. Dr Feigal has more than 30 years experience in drug development and regulation. Before joining the FDA, he worked for 10 years within the academic and hospital settings of the University of California in San Diego, San Francisco, and Davis. He holds a BA from University of Minnesota, an MD from Stanford University and a Master of Public Health from the University of California, Berkeley.